Dosage and schedules may improve effects of PI3K-inhibitors to target breast cancer t
Researchers from the Geisel School of Medicine at Dartmouth will present a scientific poster on Wednesday, April 9, 2014 at the American Association of Cancer Researchers conference in San Diego, CA.